The epidemiology of bacterial sepsis

Infectious Disease Clinics of North America

Volumn 13, Issue 2, 1999, Pages 299-312

  Rangel Frausto, M S ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; BLOOD DISEASE; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; POPULATION RESEARCH; PREDICTION; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNITED STATES;

EID: 0033041293     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70076-3     Document Type: Article

References (56)

1. American College of Chest Physicians Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 20 1992 864 875
2. Archibald L.K. den Dulk M.O. K.J. Pallangyo Fatal Mycobacterium tuberculosis bloodstream infections in febrile hospitalized patients in Dar es Salaam, Tanzania Clin Infect Dis 26 1998 290 296
3. D.W. Bates K. Sands E. Miller Predicting bacteremia in patients with sepsis syndrome J Infect Dis 176 1997 1538 1551
4. J.R. Beck S.G. Pauker The Markov process in medical prognosis Med Decis Making 3 1983 419 458
5. J. Bisbe J.M. Gatell J. Ouig Pseudomonas aeruginosa bacteremia: Univariate and multivariate analyses of factors influencing prognosis in 133 episodes Rev Infect Dis 10 1988 629 625
6. Bone R.C. Fisher C.J. Jr T.P. Clemmer Sepsis syndrome: A valid clinical entity Crit Care Med 17 1989 389 393
7. Bone R.C. Fisher C.J. Jr T.P. Clemmer A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock N Engl J Med 317 1987 653 658
8. R.C. Bone Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) Ann Intern Med 125 1996 680 687
9. R.C. Bone Sepsis syndrome: New insights into its pathogenesis and treatment Infect Dis Clin North Am 5 1991 793 805
10. R.C. Bone Sepsis, the sepsis syndrome, multiorgan failure: A plea for comparable definitions Ann Intern Med 114 1991 332 333
11. C. Brun-Bruison F. Doyon J. Carlet Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units JAMA 274 1995 968 974
12. Centers for Disease Control and Prevention, National Center for Health Statistics Mortality Patterns—United States, 1990 Monthly Vital Statistics Report 41 1993 45
13. Centers for Disease Control Increase in national hospital discharge survey rates for septicemia—United States, 1979–1987 MMWR Morb Mortal Wkly Rep 39 1990 31 34
14. Centers for Disease Control National Nosocomial Infections Study Report October 1975 Annual Summary
15. Centers for Disease Control Nosocomial infections surveillance, 1980–82 MMWR CDC Surveill Summ 32 1983 1S 16S
16. Centers for Disease Control Nosocomial infections surveillance, 1983 MMWR CDC Surveill Summ 33 1984 9S 22S
17. M.B. Edmond J.F. Ober D.L. Weinbaum Natural history and attributable morbidity and mortality of vancomycin-resistant enterococcal bacteremia Clin Infect Dis 23 1996 1234 1239
18. A.M. Fein G.R. Bernard G.J. Criner Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, Delibant (CP-0127): Results of a randomized, double-blind, placebo-controlled trial JAMA 277 1997 482 487
19. Fisher C.J. Jr J.M. Agosti S.M. Opal Treatment of septic shock with the tumor necrosis factor: Fc fusion protein N Engl J Med 334 1996 1697 1702
20. J.M. Gatell A. Trilla X. Latorre Nosocomial bacteremia in a large Spanish teaching hospital: Analysis of factors influencing prognosis in 133 episodes Rev Infect Dis 10 1988 629 635
21. H.F. Geerdes D. Ziegler H. Lode Septicemia in 980 patients at a university hospital in Berlin: Prospective studies during 4 selected years between 1979 and 1989 Clin Infect Dis 15 1992 991 1002
22. R.C. Gentleman J.F. Lawles J.C. Lindsey Multistate Markov models for analyzing incomplete disease history data with illustrations for HIV disease Stat Med 13 1994 805 821
23. S.M. Gordon J.M. Serkey T.F. Keys Secular trends in nosocomial bloodstream infections in a 55-bed cardiothoracic intensive care unit Ann Thorac Surg 65 1998 95 100
24. R.L. Greenman R.M.H. Schein M.A. Martin A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis JAMA 266 1991 1097 1111
25. J.B. Haug S. Harthung T. Kalager Bloodstream infections at a Norwegian university hospital, 1974–1979 and 1988–1989: Changing etiology, clinical features, and outcome Clin Infect Dis 19 1994 246 254
26. M. Hilf V.L. Yu J. Sharp Antibiotic therapy for Pseudomonas aeruginosa bacteremia: Outcome correlations in a prospective study of 200 patients Am J Med 87 1989 540 546
27. H. Kieft A.I.M. Hoepelman W. Zhou The sepsis syndrome in a Dutch university hospital Arch Intern Med 153 1993 2241 2247
28. S.L. Landry D.L. Kalser R.P. Wenzel Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: A controlled study Am J Infect Control 17 1989 323 329
29. M.I. Longini W.S. Clark R.H. Byers Statistical analysis of the stages of HIV infection using a Markov model Stat Med 8 1989 831 843
30. M.A. Martin M.A. Pfaller R.P. Wenzel Coagulase-negative staphylococcal bacteremia Ann Intern Med 110 1989 9 16
31. J.E. McGowan M.W. Barnes M. Finland Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935–1972), with special reference to hospital-acquired cases J Infect Dis 132 1975 316 335
32. R.R. Muder C. Brennen M.M. Wagener Bacteremia in a long-term–care facility: A five-year prospective study of 163 consecutive episodes Clin Infect Dis 14 1992 647 654
33. L.E. Myers D.F. Paulson W.R. Berry A time-dependent statistical model which relates current clinical status to prognosis. Application to advanced prostatic cancer J Chronic Dis 33 1980 491 499
34. M.S. Niederman A.M. Fein Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia: A common clinical consequence Clin Chest Med 11 1990 633 656
35. M.M. Parker J.E. Parrillo Septic shock: Hemodynamics and pathogenesis JAMA 250 1983 3324 3327
36. J.E. Parrillo N.N. Parker C. Natanson Septic shock in humans—advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy Ann Intern Med 113 1990 227 242
37. P. Peduzzi C. Shatney J. Sheagren Predictors of bacteremia and gram-negative bacteremia in patients with sepsis Arch Intern Med 152 1992 529 535
38. T.M. Perl L.A. Dvorak T. Hwang Long-term survival and function after suspected gram-negative sepsis JAMA 274 1995 338 345
39. D. Pittet N. Li R.P. Wenzel Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality Eur J Infect Dis 12 1993 813 819
40. D. Pittet S. Rangel-Frausto N. Li Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients Intensive Care Med 21 1995 302 309
41. D. Pittet D. Tarara R.P. Wenzel Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality JAMA 271 1994 1598 1601
42. D. Pittet B. Thievant R.P. Wenzel Importance of preexisting comorbidities for prognosis of septicemia in critically ill patients Intensive Care Med 19 1993 265 272
43. Ponce-de-Leon S, Molinar-Ramos F, Dominguez G, et al: Prevalence of infections in intensive care units in Mexico: A multicenter study. Crit Care Med, in press
44. Rangel-Frausto MS, Pittet D, Costigan M, et al: Risk factors for septic shock: A matched case-control study [abstract]. In Proceedings of the 35th Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, 1995; abstract J24
45. M.S. Rangel-Frausto D. Pittet M. Costigan The dynamics of disease progression in sepsis: Markov modeling describing the natural history and the likely impact of effective antisepsis agents Clin Infect Dis 27 1988 185 190
46. M.S. Rangel-Frausto D. Pittet M. Costigan The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study JAMA 273 1995 117 123
47. F.J. Roberts I.W. Gere A. Coldman A 3-year study of positive blood cultures, with emphasis on prognosis Rev Infect Dis 13 1991 34 46
48. K.C. Sasse E. Nauenberg A. Long Long-term survival after intensive care unit admission with sepsis Crit Care Med 23 1995 1040 1047
49. D.R. Schaberg D.H. Culver R.P. Gaynes Major trends in the microbiology etiology of nosocomial infections Am J Med 91 1991 72S 75S
50. T. Towsend R.P. Wenzel Nosocomial bloodstream infections in a newborn intensive care unit: A case-matched control study of morbidity, mortality and risk Am J Epidemiol 114 1981 73 80
51. R.P. Wenzel Anti-endotoxin monoclonal antibodies: A second look N Engl J Med 326 1992 1151 1153
52. R.P. Wenzel The mortality of hospital-acquired bloodstream infections: Need for a new vital statistic? Int J Epidemiol 17 1988 225 227
53. S.B. Wey M. Mori M.A. Pfaller Hospital-acquired candidemia: The attributable mortality and excess length of stay Arch Intern Med 148 1988 2642 2645
54. S.B. Wey M. Mori M.A. Pfaller Risk factors for hospital-acquired candidemia Arch Intern Med 149 1989 2349 2353
55. Ziegler E.J. Fisher C.J. Jr C.L. Sprung Treatment of gram-negative bacteremia and septic shock with a HA-1a human monoclonal antibody against endotoxin: A randomized, double-blind, placebo-controlled trial N Engl J Med 324 1991 429 436
56. E.J. Ziegler J.A. McCutchan J. Fierer Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli N Engl J Med 307 1982 1225 1230